Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Use and misuse of ezetimibe: analysis of use and cost in Saskatchewan, a Canadian jurisdiction with broad access.

Alsabbagh WM, Dagenais J, Yan L, Lu X, Lix LM, Shevchuk Y, Teare GF, Blackburn DF.

Can J Cardiol. 2014 Feb;30(2):237-43. doi: 10.1016/j.cjca.2013.11.031. Epub 2013 Dec 8.

PMID:
24461925
[PubMed - indexed for MEDLINE]
2.

Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data registries.

Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Wilkinson A, Durrington P, Chilcott J.

Clin Ther. 2008 Aug;30(8):1508-23. doi: 10.1016/j.clinthera.2008.08.002.

PMID:
18803993
[PubMed - indexed for MEDLINE]
3.

Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.

PMID:
18485273
[PubMed - indexed for MEDLINE]
Free Article
4.

Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.

Toth PP, Ballantyne CM, Davidson MH, Tomassini JE, Ramey DR, Neff D, Tershakovec AM, Hu XH, Tunceli K.

J Clin Lipidol. 2012 Mar-Apr;6(2):180-91. doi: 10.1016/j.jacl.2011.11.007. Epub 2011 Dec 7.

PMID:
22385552
[PubMed - indexed for MEDLINE]
5.

Ezetimibe--a new cholesterol-lowering drug.

[No authors listed]

Drug Ther Bull. 2004 Sep;42(9):65-7.

PMID:
15373326
[PubMed - indexed for MEDLINE]
6.

Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.

Cook JR, Yin D, Alemao E, Davies G, Krobot KJ, Veltri E, Lipka L, Badia X.

Pharmacoeconomics. 2004;22 Suppl 3:49-61.

PMID:
15669153
[PubMed - indexed for MEDLINE]
7.

Ezetimibe for lowering blood cholesterol.

Husereau DR.

Issues Emerg Health Technol. 2003 Sep;(49):1-4.

PMID:
14533615
[PubMed - indexed for MEDLINE]
8.

Use of ezetimibe in the United States and Canada.

Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM.

N Engl J Med. 2008 Apr 24;358(17):1819-28. doi: 10.1056/NEJMsa0801461. Epub 2008 Mar 30.

PMID:
18375999
[PubMed - indexed for MEDLINE]
Free Article
9.

Ezetimibe: a selective cholesterol absorption inhibitor.

Nutescu EA, Shapiro NL.

Pharmacotherapy. 2003 Nov;23(11):1463-74. Review.

PMID:
14620392
[PubMed - indexed for MEDLINE]
10.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
[PubMed - indexed for MEDLINE]
11.

Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.

Sampalis JS, Bissonnette S, Habib R, Boukas S; Ezetrol Add-On Investigators.

Ann Pharmacother. 2007 Sep;41(9):1345-51. Epub 2007 Jul 31.

PMID:
17666579
[PubMed - indexed for MEDLINE]
12.

Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model.

Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Rees A, Wilkinson A, Durrington P, Chilcott J.

Am J Cardiovasc Drugs. 2008;8(6):419-27. doi: 10.2165/0129784-200808060-00005.

PMID:
19159125
[PubMed - indexed for MEDLINE]
13.

Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia.

Cook JR, Yin D, Alemao E, Drummond M.

Pharmacoeconomics. 2004;22 Suppl 3:37-48.

PMID:
15669152
[PubMed - indexed for MEDLINE]
14.

Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada.

Kohli M, Attard C, Lam A, Huse D, Cook J, Bourgault C, Alemao E, Yin D, Marentette M.

Pharmacoeconomics. 2006;24(8):815-30.

PMID:
16898850
[PubMed - indexed for MEDLINE]
15.

Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada.

Lu L, Krumholz HM, Tu JV, Ross JS, Ko DT, Jackevicius CA.

Am Heart J. 2014 May;167(5):683-9. doi: 10.1016/j.ahj.2014.01.014. Epub 2014 Feb 26.

PMID:
24766978
[PubMed - indexed for MEDLINE]
16.

Ezetimibe: a novel option for lowering cholesterol.

Davidson MH.

Expert Rev Cardiovasc Ther. 2003 May;1(1):11-21. Review.

PMID:
15030293
[PubMed - indexed for MEDLINE]
17.

Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.

Bissonnette S, Habib R, Sampalis F, Boukas S, Sampalis JS; Ezetrol Add-On Investigators.

Can J Cardiol. 2006 Oct;22(12):1035-44. Erratum in: Can J Cardiol. 2007 Feb;23(2):159.

PMID:
17036098
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.

Lipka LJ.

Cardiovasc Drug Rev. 2003 Winter;21(4):293-312. Review.

PMID:
14647533
[PubMed - indexed for MEDLINE]
19.

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL.

Curr Med Res Opin. 2007 Aug;23(8):2009-26.

PMID:
17659159
[PubMed - indexed for MEDLINE]
20.

Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerability.

Baruch L, Gupta B, Lieberman-Blum SS, Agarwal S, Eng C.

Am J Manag Care. 2008 Oct;14(10):637-41.

PMID:
18837641
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk